Back to Clinical Trials Overview

Your search for "Liver Disorders" returned 13 results:


Genomics of Primary Biliary Cirrhosis
Principal Investigator(s): Joseph Odin

A Phase 2, randomized, multicenter, placebo-controlled, double-blind, parallel-group study to evaluate the efficacy, safety and population PKs of once-daily oral E5501 tablets used up to 7 days in subjects with chronic liver diseases and thrombocytopenia prior to elective surgical or diagnostic procedures
Principal Investigator(s): Chang, Charissa

Characterization of Acute HCV Infection
Principal Investigator(s): Fierer, Daniel S

Entecavir (ETV) in Pediatric Subjects w/HBV & HBeAG-+
Principal Investigator(s): Kerkar, Nanda

A Phase III Double Blind Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Treatment-Naïve Subjects with Chronic HCV GT1, GT4 and GT6 Infection with Inherited Blood Disorders with and without HIV Co-Infection
Principal Investigator(s): Ponni Perumalswami

Biliary Atresia Study in Infants and Children (BASIC)
Principal Investigator(s): Suchy, Frederick J.

Longitudinal Study of Mitochondrial Hepatopathies (MITOHEP)
Principal Investigator(s): Suchy, Frederick J.

HCC BRIDGE study: Bridge to better outcomes in HCC
Principal Investigator(s): Schwartz, Myron MD

A Rollover Protocol to Provide Open-Label Emtricitabine/Tenofovir Disoproxil Fumarate Combination Product to Subjects Completing the GS-US-203-0107 Study. Protocol GS-US-203-0109
Principal Investigator(s): Schiano, Thomas

Cholestatic Liver Disease Consortium- Longitudinal Studies of Genetic Causes of Intrahepatic Cholestasis(LOGIC)
Principal Investigator(s): Suchy, Frederick J.

Prospective Database of Infants with Cholestasis (PROBE)
Principal Investigator(s): Suchy, Frederick J.

A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase Like 2 (LOXL2) in Subjects with Primary Sclerosing Cholangitis (PSC)
Principal Investigator(s): Joseph Odin

Corticosteroid Therapy in Infants w/ Bilary Atresia (START Trial)
Principal Investigator(s): Suchy, Frederick J.